Active ingredientMigalastat HClCat. No. P-M126-001CAS 75172-81-5Family · Pharmaceutical analytical standards
Migalastat
A pharmacological chaperone for Fabry disease: it binds the misfolded enzyme alpha-galactosidase A and helps it work, in patients with 'amenable' mutations. It was authorised in the European Union in 2016 and in the US in 2018. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It is an iminosugar resembling galactose, with a nitrogen atom instead of oxygen in its ring: it was isolated in 1988 as a fermentation product of the bacterium Streptomyces lydicus, under the name 1-deoxygalactonojirimycin.
Go to the active ingredient →Active ingredientMigalastat HClCat. No. P-M126-001CAS 75172-81-5
MetaboliteMigalastat O-beta-D-Glucuronide Sodium SaltCat. No. P-M126-002
Isotopically labelledMigalastat-15N HClCat. No. P-M126-003
Isotopically labelledMigalastat-d2Cat. No. P-M126-004
NitrosamineN-Nitroso MigalastatCat. No. P-M126-005
ImpurityLucerastatCat. No. P-M126-006CAS 141206-42-0
ImpurityMigalastat Impurity 1Cat. No. P-M126-007No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.